An elevated white blood cell (WBC) count and C-reactive protein (CRP) concentration are associated with acute myocardial infarction (AMI) and long-term mortality in patients with coronary artery disease. Their relationship with short-term prognosis following AMI is less clear, however. We investigated the relationship between WBC count and CRP concentration, obtained at the time of admission, and the development of subsequent ischaemic coronary events (SICE) within 30 days of AMI in 177 patients. After adjustment for confounding factors, CRP concentration was found to be a strong independent predictor for SICE within 30 days in patients with AMI. WBC count was not found to be an independent predictor, but there was a strong correlation between high WBC counts and the onset of SICE within 30 days in patients with AMI. We conclude that CRP concentration and WBC count could be used to predict the short-term prognosis of patients with AMI.
RidkerPMCushmanMStampferMJTracyRPHennekensCH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med1997; 336: 973–979.
2.
RidkerPMHennekensCHBuringJERifaiN: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med2000; 342: 836–843.
3.
HaverkateFThompsonSGPykeSDGallimoreJRPepysMB: Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet1997; 349: 462–466.
4.
MorrowDARifaiNAntmanEMWeinerDLMcCabeCHCannonCP: C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol1998; 31: 1460–1465.
5.
HeeschenCHammCWBruemmerJSimoonsML: Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol2000; 35: 1535–1542.
6.
FerreirosERBoissonnetCPPizarroRMerlettiPFCorradoGCagideA: Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation1999; 100: 1958–1963.
7.
LindahlBTossHSiegbahnAVengePWallentinL: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med2000; 343: 1139–1147.
8.
ZebrackJSMuhlesteinJBHorneBDAndersonJL: Intermountain Heart Collaboration Study Group: C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol2002; 39: 632–637.
9.
PietilaKHarmoinenAHermensWSimoonsMLVan de WerfFVerstraeteM: Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J1993; 14: 915–919.
10.
TommasiSCarluccioEBentivoglioMBuccolieriMMariottiMPolitanoM: C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol1999; 83: 1595–1599.
11.
ZebrackJSAndersonJLMaycockCAHorneBDBairTLMuhlesteinJB: Intermountain Heart Collaboration (IHC) Study Group: Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol2002; 89: 145–149.
12.
De SutterJDe BuyzereMGheeraertPVan de WieleCVoetJDe PauwM: Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis2001; 157: 189–196.
13.
FriedmanGDKlatskyALSiegelaubAB: Letter: Leukocyte count and myocardial infarction: Correction. N Engl J Med1974; 291: 1361.
14.
PrenticeRLSzatrowskiTPFujikuraTKatoHMasonMWHamiltonHH: Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol1982; 116: 496–509.
15.
BovillEGBildDEHeissGKullerLHLeeMHRockR: White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. Am J Epidemiol1996; 143: 1107–1115.
16.
LoweGDMachadoSGKrolWFBartonBAForbesCD: White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost1985; 54: 700–703.
17.
SchlantRCFormanSStamlerJCannerPL: The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation1982; 66: 401–414.
18.
BurrMLHollidayRMFehilyAMWhiteheadPJ: Haematological prognostic indices after myocardial infarction: Evidence from the Diet And Reinfarction Trial (DART). Eur Heart J1992; 13: 166–170.
19.
KrumholzHMChenJWangYRadfordMJChenYTMarciniakTA: Comparing AMI mortality among hospitals in patients 65 years of age and older: Evaluating methods of risk adjustment. Circulation1999; 99: 2986–2992.
20.
AlpertJSThygesenKAntmanEBassandJP: Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol2000; 36: 959–969.
21.
SchillerNBShahPMCrawfordMDeMariaADevereuxRFeigenbaumH: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr1989; 2: 358–367.
22.
BarronHVHarrSDRadfordMJWangYKrumholzHM: The association between white blood cell count and acute myocardial infarction mortality in patients > or = 65 years of age: Findings from the cooperative cardiovascular project. J Am Coll Cardiol2001; 38: 1654–1661.
23.
MuellerCBuettnerHJHodgsonJMMarschSPerruchoudAPRoskammH: Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation2002; 105: 1412–1415.
24.
SuleimanMAronsonDReisnerSAKapeliovichMRMarkiewiczWLevyY: Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med2003; 115: 695–701.
25.
PietilaKOHarmoinenAPJokiniittyJPasternackAI: Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J1996; 17: 1345–1349.
26.
AnzaiTYoshikawaTShirakiHAsakuraYAkaishiMMitamuraH: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation1997; 96: 778–784.
27.
FurmanMIBeckerRCYarzebskiJSavegeauJGoreJMGoldbergRJ: Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol1996; 78: 945–948.
28.
BarronHVCannonCPMurphySABraunwaldEGibsonCM: Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation2000; 102: 2329–2334.
29.
LagrandWKVisserCAHermensWTNiessenHWVerheugtFWWolbinkGJ: C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?Circulation1999; 100: 96–102.
30.
PinckardRNOlsonMSGiclasPCTerryRBoyerJTO'RourkeRA: Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest1975; 56: 740–750.
31.
KilgoreKSFriedrichsGSHomeisterJWLucchesiBR: The complement system in myocardial ischaemia/reperfusion injury. Cardiovasc Res1994; 28: 437–444.
32.
MatheyDSchoferJSchaferHJHamdochTJoachimHCRitgenA: Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J1994; 15: 418–423.
33.
LagrandWKNiessenHWWolbinkGJJasparsLHVisserCAVerheugtFW: C-reactive protein co-localizes with complement in human hearts during acute myocardial infarction. Circulation1997; 95: 97–103.
34.
GriselliMHerbertJHutchinsonWLTaylorKMSohailMKrauszT: C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med1999; 190: 1733–1740.
35.
WeismanHFBartowTLeppoMKMarshHCJrCarsonGRConcinoMF: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science1990; 249: 146–151.
